BioNTech to acquire Novartis’ Marburg manufacturing plant to expand production of COVID-19 vaccine candidates
Biopharmaceutical New Technologies (BioNTech) has agreed to acquire a GMP certified manufacturing facility in Marburg, Germany from Novartis to expand the production capacity of its ... Read More
Pfizer, BioNTech sign deal to supply BNT162 Covid-19 vaccine to Canada
Pfizer and BioNTech have signed an agreement with the Canadian government to supply their mRNA-based BNT162 vaccine candidate against SARS-CoV2, depending on clinical success and ... Read More
BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech
Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses of their jointly developed BNT162 COVID-19 vaccine ... Read More
BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status
Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2 virus have been given the fast track ... Read More
BioNTech and Pfizer forge $425m partnership to develop mRNA-based flu vaccines
In a significant advancement in vaccine research, German biotech firm BioNTech has partnered with American pharmaceutical giant Pfizer in a multi-year research and development collaboration ... Read More